(Q43205844)

English

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide D

scientific article published in January 2010

Statements

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide D (English)
Ib Jarle Christensen
Ulrik Tarp
Lene Dreyer
Annette Hansen
Ib Tønder Hansen
Gina Kollerup
Louise Linde
Uta Engling Poulsen
Annette Schlemmer
Dorte Vendelbo Jensen
Signe Jensen
Gisela Hostenkamp
Mikkel Østergaard
All Departments of Rheumatology in Denmark
1 January 2010
22-32

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit